Pinto Moshe 4/A
4/A · NEPHROS INC · Filed Dec 20, 2018
Insider Transaction Report
Form 4/AAmended
NEPHROS INCNEPH
Pinto Moshe
Director
Transactions
- Award
Common Stock
2018-12-14+47,673→ 204,118 total
Holdings
- 33,880
Stock Option (Right to Buy)
Exercise: $0.40Exp: 2026-08-24→ Common Stock (33,880 underlying) - 59,155
Stock Option (Right to Buy)
Exercise: $0.45Exp: 2025-08-14→ Common Stock (59,155 underlying) - 40,284
Stock Option (Right to Buy)
Exercise: $0.50Exp: 2027-12-20→ Common Stock (40,284 underlying)
Footnotes (3)
- [F1]On December 14, 2018, the Company granted 47,673 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Pinto in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). The Restricted Stock vests 6 months following the grant date.
- [F2]Fully exercisable.
- [F3]The option vests as to 13,428 shares on each of 12/20/17, 12/20/18 and 12/20/19.